| 000 | 01017 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513061346.0 | ||
| 264 | 0 | _c19930817 | |
| 008 | 199308s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/0140-6736(93)91845-d _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDonckier, J | |
| 245 | 0 | 0 |
_aShrinkage of inoperable adenomas in cavernous sinus with high-dose octreotide. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cJul 1993 |
||
| 300 |
_a301 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 |
_aAdenoma _xdrug therapy |
| 650 | 0 | 4 | _aCavernous Sinus |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOctreotide _xtherapeutic use |
| 650 | 0 | 4 |
_aVascular Diseases _xdrug therapy |
| 700 | 1 | _aGilliard, C | |
| 700 | 1 | _aBuysschaert, M | |
| 773 | 0 |
_tLancet (London, England) _gvol. 342 _gno. 8866 _gp. 301 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0140-6736(93)91845-d _zAvailable from publisher's website |
| 999 |
_c8100644 _d8100644 |
||